Press Release

Printer Friendly Version View printer-friendly version
<< Back
Nuvectra to Present at the 29th Annual ROTH Conference

PLANO, Texas, March 06, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the 29th Annual ROTH Conference in Dana Point, CA. Management will also be available for one-on-one meetings at the conference.

Event:  29th Annual ROTH Conference
Date:  Monday, March 13, 2017
Time:  1:00 pm PT

A webcast of the Company’s presentation will be available by visiting the investor relations section of Nuvectra’s website at www.nuvectramed.com. A webcast replay of the presentation will be available for 90 days.

About Nuvectra Corporation

Nuvectra™ is a neurostimulation company committed to helping physicians improve the lives of people with chronic neurological conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS). In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com.

Company Contacts:
Nuvectra Corporation

Walter Berger, Chief Operating Officer and Chief Financial Officer
(214) 474-3102
wberger@nuvectramed.com

Jennifer Armstrong, Media Relations
(214) 474-3110
jarmstrong@nuvectramed.com

Investor Contacts:
The Ruth Group

Nick Laudico
(646) 536-7030
nlaudico@theruthgroup.com

Zack Kubow
(646) 536-7020
zkubow@theruthgroup.com

Nuvectra